Background and purpose Renal dysfunction (i.e. a reduced estimated glomerular filtration rate, eGFR) is commonly found in hospitalized stroke patients but its associations with patients' characteristics and outcome require further investigation. Methods We linked clinical data from stroke patients enrolled between 2005 and 2008 into two prospective hospital registers with routine laboratory eGFR data. The eGFR was calculated using the Modification of Diet in Renal Disease method and renal dysfunction was defined as <60 ml/min/1·73 m 2 . In addition we systematically reviewed studies investigating the association between eGFR and outcome after stroke. Results Of 2520 patients who had an eGFR measured on admission hospital, 805 (32%) had renal dysfunction. On multivariate analysis, renal dysfunction was significantly less likely in those with a predicted good outcome (OR 0·27, 95% CI 0·21, 0·36) based on the well-validated six simple variable model. After adjustment for other predictive factors, stroke patients with renal dysfunction were more likely to die in hospital compared with those without (odds ratio 1·59, 95% confidence intervals 1·26, 2·00). Of the 31 studies involving 41 896 participants included in the systematic review, 18 studies found that low eGFR was an independent predictor of death and 6 reported a significant association with death and disability. Conclusion Our findings suggest that renal dysfunction on admission is common and associated with poor outcomes over the first year. Further work is required to establish to what extent these associations are causal and whether treating impaired renal function improves outcomes.
Introduction
Renal dysfunction, defined as a low estimated glomerular filtration rate (eGFR) (<60 ml/min/1·73 m 2 ), is independently associated with the risk of first-ever stroke in the general population (1) . Clinical guidelines therefore recommend screening patients at risk of cardiovascular disease for renal dysfunction with eGFR (2) . There are also concerns that renal dysfunction in the acute phase of stroke is associated with increased bleeding risk after an ischemic stroke (IS) (3), reduced efficacy of thrombolysis (4), adverse effects of contrast agents used for multimodel tomography (CT) imaging (5) , the high frequency of dehydration (6) , and the safety of renally excreted medications, including the new anticoagulants (7) .
We aimed to investigate what clinical factors on admission are associated with renal dysfunction and estimate the strength of any independent association between low eGFR rates and outcome by adjusting for other prognostic variables including the extensively validated six simple variable (SSV) model in a large in-hospital stroke population (8) . We also reviewed available studies to determine whether eGFR on admission was associated with outcomes after stroke.
Methods

Cohort study
Patients
We included all consecutive stroke admissions prospectively registered in the Scottish Stroke Care Audit (SSCA) from two teaching hospitals within 14 days of stroke onset between 1 January 2005 and 30 December 2008 (9) . We included patients with first ever recorded IS and intracerebral hemorrhage (ICH) stroke, but excluded those with subarachnoid hemorrhage using brain imaging. We also excluded patients who had a stroke while in-hospital or who had transient ischemic attack (TIA, symptoms <24 h duration). The SSCA did not record if patients had chronic renal dysfunction prior to admission, therefore these patients are included in the analyses. To adjust for stroke severity we used the SSV model (age, living alone, independence in activities of daily living before the stroke, the verbal component of the Glasgow Coma Scale, arm power, and the ability to walk) to predict outcomes after stroke (8) .
Ethics
Full ethical approval was not required as it aimed to inform local practice, involved linking routinely available data sets and did not involve any patient identifiable data. The study was approved by the Caldicott Guardian.
Measurements and outcomes
Estimated GFR was calculated using the MDRD equation with the formula for isotope dilution mass spectrometry (IDMS) = 175 × [serum creatinine, SCr] −1·154 × [age] −0·203 × 0·742 (if female) (2) . However, between 2005 and 2007 the SCr was not standardized to IDMS, so a factor of 186 (rather than 175) was used when using non-IDMS spectrometry (10) . Ethnicity was not included in the equation as almost all the population admitted to the hospitals during this period were white. As recommended by the National Kidney Foundation our laboratory reported normal renal function over 60 as >60 due to the tendency for MDRD equation to underestimate normal function (2) . Renal dysfunction was therefore defined as <60 ml/min/1·73 m 2 (2) . We further categorized renal dysfunction into moderate (eGFR = 30-59 ml/min/ 1·73 m 2 ) and severe (<30 ml/min/1·73 m 2 ).
Analyses
Univariate associations between renal dysfunction, the SSV model, and other available clinical factors were investigated with chi-square tests. Logistic regression models were used to identify independent associations between the significant explanatory factors in the univariate analysis and renal dysfunction and then to determine the association with renal dysfunction and patient outcomes at hospital discharge. Data analyses were performed using IBM SPSS statistics for windows, Version 20.0, 2011 (IBM Corp Armonk, NY, USA) and SAS® 9·2 Enhanced Logging Facilities (SAS Institute Inc., Cary, NC, USA).
Systematic review
The initial search strategy included key stroke subject terms used by the Cochrane Stroke Group (11) . We also included renal function, renal dysfunction, estimated glomerular filtration rate, prognosis, death, mortality, morbidity, case fatality, disability, dependence, and independence. The MEDLINE, CINAHL, and AMED databases using EBSCO host were searched, restricted to adult, human, and English language studies from earliest date to October 2013. Only studies that met the following criteria were Data are median (IQR) or number (%). *Chi-square (df = 2). † Factors included in the SSV model to predict probability of stroke severity (8) .
Non-parametric Mann-Whitney tests were used to compare the differences between medians and chi-square tests for nominal data. ACE, angiotensin converting enzyme; TACS, total anterior circulation stroke. 
A. Rowat et al. included: results reported for acute stroke (IS and/or ICH); eGFR measured on hospital admission; and outcome measures of death and/or disability. All potentially relevant articles were read in full and reference lists were scrutinized to identify further studies. Abstracts, conference proceedings and letters were excluded because of lack of reporting detail. A data extraction form was developed to collect data on the study design, stroke pathology, methods, maximum follow-up, effect measures and outcomes. Odds ratios (OR) were extracted from logistic regression models or calculated from 2 × 2 tables. Studies reporting hazard ratios from survival analyses were also included.
Results
A total of 2591 patients were identified in our local cohorts. We excluded 71 (2·7%) patients in whom eGFR could not be calculated. Of the 2520 remaining patients, 805 (32%) had renal dysfunction. Table 1 shows stroke patients with renal dysfunction were significantly more likely to be: older; female; prescribed antihypertensive medication, angiotensin converting enzyme inhibitors or diuretics; dependent in activities of daily living prior to the stroke; living alone; and unable to talk, not orientated or unable to walk after the stroke (P < 0·05). Neither stroke pathology or clinical classification differed significantly between those with and without renal dysfunction. 
Univariate comparisons of clinical characteristics
Factors associated with renal dysfunction on admission
Significant factors (P < 0·05) in the univariate analysis as well as stroke pathology, which was approaching statistical significance, were included in logistic regression model. After removing sequentially those variables that failed to reach statistical significance, a final model showed that renal dysfunction on admission was significantly less likely in men, in patients with ICH, and in those with a predicted good outcome, but more likely in those prescribed diuretics (P ≤ 0·001) ( Table 2 ).
Outcomes at discharge
Discharge destination was known for 2481 patients (n = 39 missing). Stroke patients with moderate (185/690, 27%) and severe (25/102, 25%) renal dysfunction were significantly more likely to die in hospital compared with those without (255/1689, 15%) (chi-square = 52·04, df = 4, P < 0·0001). After adjustment for other predictive variables, eGFR <60 ml/min/1·73 m 2 was found to be an independent predicator of death in-hospital (OR 1·59, 95% CI 1·26, 2·00). Further analyses of the subcategories of renal dysfunction confirmed that moderate renal dysfunction (eGFR <60, ≥30 ml/min/1·73 m 2 ) was independently associated with death in hospital (OR 1·67, 95% CI 1·31, 2·13), but severe renal dysfunction (eGFR <30 ml/min/1·73 m 2 ) was not (OR 1·30, 95% CI 0·78, 2·18).
Systematic review
The initial search identified 1293 non-duplicate articles of which 31 studies met the inclusion criteria ( Fig. 1 ). There were a total of 41 896 participants: 13 241 had an IS; 6707 had an IS and were thrombolyzed; 3135 an ICH, 90 a TIA, and for 18 723 the pathology was not specified . Thirteen studies were performed in Europe (13, 16, 18, 20, (26) (27) (28) (29) 33, 35, 37, 39, 40) , 10 in Asia (14, 17, 19, 21, 22, 25, 30, 32, 38, 41) , 6 in the United States (12, 15, 31, 34, 36, 42) , and 2 in Brazil (23, 24) . Twenty-two studies measured the frequency of eGFR < 60 ml/min/1·73 m 2 , but studies used different formulae to calculate eGFR including: Modification of Diet in Renal Disease (MDRD) (12) (13) (14) (15) (16) (17) (19) (20) (21) (22) 25, 26, 28, (30) (31) (32) (33) (34) (35) (36) (37) (39) (40) (41) (42) ; Crockcault-Croft (23, 29, 38) ; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) (18, 24, 27, 41) ; and Mayo Clinical Quadratic Equation (MCQE) (42) . Only one study reported using different formulae depending on whether or not creatinine was measured by IDMS methods (35) . Among 12 studies that reported combined outcomes of death and disability, 6 reported a significant association with low eGFR (Fig. 2) (15, 18, 19, 28, 32, 41) . Of 13 studies that reported death 
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after stroke, 8 (including the present study) reported that low eGFR was an independent predictor of mortality (in-hospital − one-year), after adjusting for confounding factors such as age, gender, and stroke severity (17, 18, 25, 32, 38, 41, 42) (Fig. 3) . A further 14 studies applied survival analysis: 2 found that low eGFR was a predictor of early (in-hospital -30 days) mortality (13, 20) ; and in 9 found it was a predictor of late (1-10 years) mortality (24, 26, (29) (30) (31) 33, 35, 39, 40) (Fig. 4 ). One study also reported that a high eGFR (>120) was associated with increase risk of death in younger stroke patients (35) . Thirteen studies used different eGFR cut-offs or definitions of renal dysfunction making it difficult to compare and/or combine effect measures (20, 22, 23, 25, (27) (28) (29) (30) 36, 37, 39, 41, 42) .
Discussion
This study found that a third of stroke patients had a low eGFR (<60 ml/min/1·73 m 2 ) on the day of admission, which is similar to other studies that used the MDRD equation to estimate GFR (13, 22, 31, 32, 37, 39, 40, 42) . However, the systematic review found that the prevalence of renal dysfunction in patients with acute stroke varies between 5% to 61% in different populations, depending on the definitions of renal dysfunction used and methods used to calculate eGFR . We found that low eGFR remained significantly more common in female stroke patients, which may be as a result of differences in the effects of sex hormones on renal physiology as well as responses to ischemia and reperfusion (43) . Patients prescribed diuretics were also more likely to have renal dysfunction and poorer outcomes. However, it remains controversial whether diuretics worsen renal function, perhaps as a result neurohumoral mechanisms, but this requires further investigation in larger prospective studies (44) . This is the first study to use the externally validated SSV model to adjust for prognostic factors (8) . Our results support the results of four studies included in our systematic review, confirming that low eGFR was an independent predictor of death in-hospital (17, 20, 25, 38) . The review also highlights that low eGFR is an independent predictor of poor long-term survival (24, 26, (29) (30) (31) 33, 35, (39) (40) (41) . However, 12 studies found no significant association between low eGFR and death (12, 16, 19, 21, 23, 27, 36, 37, 42) and/or combined outcomes of death and disability (12, 14, 22, 34, 37, 42) . [Correction added after first online publication on 12th March 2014: Twelve studies (not 13) found no significant association between low eGFR and death. The sentence is now amended, and an additional reference ('12') is now added to the list of citations.] The statistical heterogeneity across studies is probably as a result of the differences in study methodology. However, our findings and the majority of studies in the review do provide further support to the importance of measuring eGFR on admission to hospital to potentially reduce deleterious effects of renal dysfunction after stroke.
A major limitation of this study is that renal function was estimated, although direct measurement is expensive and not used in everyday clinical practice. Our laboratory used the MDRD to calculate eGFR, which has mainly been validated in patients with impaired renal function. However, there is growing support that future studies use the CKD-EPI to calculate eGFR, which may be more accurate in older patients with chronic disease such as stroke (45) . Second, eGFR was categorized, rather than used as a continuous measure, and was measured on admission, whereas it would be ideal to verify renal function on several measurements. Third, we did not record previous renal dysfunction or other indicators of renal function, such as proteinuria and microalbuminuria, which others have suggested may more accurately predict stroke outcomes than eGFR (34) . The retrospective nature of the analysis, means that we could not study unmeasured confounding such as risk factors, other medications, clinical indices and comorbidities that might be associated with renal dysfunction. We did try and avoid possible selection bias by retrieving data for all patients in our database during the study period. Fourth, we determined outcomes at hospital discharge, rather than at a fixed time after stroke admission or onset so that our results may be confounded by length of hospital stay. Lastly, meta-analysis would not have been appropriate due to significant methodological heterogeneity across the observational studies included in the systematic review.
Conclusions
The results of this study supports the growing body of evidence that renal dysfunction is common in stroke patients on admission to hospital and is a strong independent predictor of poor outcome at hospital discharge. Larger prospective studies are warranted to determine if this association is causal and whether treatment aimed at improving eGFR might improve stroke outcomes.
